Date palm is one of the most economically important woody crops cultivated in the Middle East and North Africa and is a good candidate for improving agricultural yields in arid environments. Nonetheless, long generation times (5-8 years) and dioecy (separate male and female trees) have complicated its cultivation and genetic analysis. To address these issues, we assembled a draft genome for a Khalas variety female date palm, the first publicly available resource of its type for a member of the order Arecales. The ~380 Mb sequence, spanning mainly gene-rich regions, includes >25,000 gene models and is predicted to cover ~90% of genes and ~60% of the genome. Sequencing of eight other cultivars, including females of the Deglet Noor and Medjool varieties and their backcrossed males, identified >3.5 million polymorphic sites, including >10,000 genic copy number variations. A small subset of these polymorphisms can distinguish multiple varieties. We identified a region of the genome linked to gender and found evidence that date palm employs an XY system of gender inheritance.
Recent research efforts provided compelling evidence of genome-wide DNA methylation alterations in aging and age-related disease. It is currently well established that DNA methylation biomarkers can determine biological age of any tissue across the entire human lifespan, even during development. There is growing evidence suggesting epigenetic age acceleration to be strongly linked to common diseases or occurring in response to various environmental factors. DNA methylation based clocks are proposed as biomarkers of early disease risk as well as predictors of life expectancy and mortality. In this review, we will summarize key advances in epigenetic clocks and their potential application in precision health. We will also provide an overview of progresses in epigenetic biomarker discovery in Alzheimer's, type 2 diabetes, and cardiovascular disease. Furthermore, we will highlight the importance of prospective study designs to identify and confirm epigenetic biomarkers of disease.
Background and Objective: The Arabian oryx (Oryx leucoryx) was hunted to near extinction in from the 1950s to the 1970s. Thus, the oryx ranks among the rarest mammals in the world. Qatar currently has ~800 oryx and has donated numerous oryx to breeding programs around the world. As such, Qatar may be a significant source of genetic diversity to the worldwide oryx population. The primary purpose of this project was to provide a genome sequence and Single Nucleotide Polymorphism (SNP) data in hopes it can be used for improving breading strategies by maintaining as much genetic diversity as possible. Methods: A DNA sample was provided from an oryx male in the Wabra Wildlife Preservation in Qatar. The animal's whole genome was sequenced using next-generation sequencing approach. After assembling the contigs, we utilized a 67bp kmer and ~2.4B paired 100bp (~80X coverage) reads from the Illumina HiSeq. These reads were distributed across libraries ranging in size from 300-1200bp for paired-end and 2000-5000bp for mate-pair libraries. Genome physical coverage by mate-pair libraries was approximately 15X. De novo gene prediction was conducted on scaffolds >500bp. SNPs were also detected. Results: Predicted genome size of ~3Gb (similar to other Mammals), a scaffold N50 of ~300kb, an assembly spanning ~2.5Gb of the genome which is likely >90% of euchromatic sequence. The sequence is distributed across 36,964 scaffolds greater than 500bp. We detected ~1M SNPs between parental alleles, which is significantly fewer than in other "rare" animals such as the giant panda. Conclusion: The initial analysis of polymorphisms suggests a relatively high level of inbreeding, and further study will be needed to clarify whether this is only in certain herds or a worldwide issue.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.